Navigation Links
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
Date:5/8/2008

42 2,080

Shareholders' equity 2,053 1,866

Reconciliation of Adjusted Earnings to GAAP Earnings; EBITDA

To supplement its consolidated financial statements presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"), the Company is providing the supplemental financial information contained below to reflect (1) the adjusted earnings per share effect of certain unusual or infrequent charges or benefits that were taken or received in the quarter ended March 31, 2008, and (2) the calculation of EBITDA for each period presented.

Adjusted earnings per share and EBITDA are non-GAAP financial measures. The Company is providing this information, however, because it believes that such information is useful to both management and investors in that it facilitates analysis by both management and investors in evaluating the Company's performance and trends. The presentation of this additional information is not meant to be considered in isolation of, or as a substitute for, results prepared in accordance with GAAP.

Barr Pharmaceuticals, Inc. Selected Adjusted Financial Data

(in millions, except per share amounts)

Three Months Ended March 31, 2008

Adjusted

GAAP Adjustments Earnings

Revenues:

Product sales $565 - $565

Alliance and

development revenue 32 - 32

Other revenue 11 (5) (b) 6

Total revenues 608 (5) 603

Costs and expenses:

Cost of sales 275 (55) (b),(c),(d),(f) 220

Selling, general and

adm
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
2. Dendreon Reports First Quarter 2008 Financial Results
3. Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results
4. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
5. Oncothyreon Reports First Quarter 2008 Financial Results
6. iCAD Reports First Quarter 2008 Financial Results
7. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
8. American Oriental Bioengineering Reports First Quarter 2008 Financial Results
9. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
10. Onyx Pharmaceuticals Reports 2008 First Quarter Results
11. AtriCure Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... (PRWEB) April 01, 2015 Shimadzu ... chromatography-based Nexera Unified Chromatography system (Nexera UC) received ... Pittsburg Conference on Analytical Chemistry and Applied Spectroscopy ... 8th and 12th. , The Pittcon Editors’ ... Pittcon for the first time based on votes ...
(Date:4/1/2015)... , April 1, 2015  ValGenesis Inc., the ... announced today that it has completed its Service Organization ... Attest Engagements (AICPA, Professional Standards) for the period of ... 2014.  ... The SOC 2 ...
(Date:4/1/2015)... IRVINE, CA (PRWEB) April 01, 2015 ... in Personalized Medicine , presented two scientific posters ... City, Utah, last week. The four-day event was hosted ... 2,000 genetic specialists dedicated to educating genetic and genomic ... Biosciences presented Genetics and Insomnia: Study on the Role ...
(Date:4/1/2015)... DIEGO , April 1, 2015  Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... three-dimensional kidney tissue at the 2015 Experimental Biology ... "Kidney represents an ideal extension ... that can be tremendously useful in pharmaceutical research," ...
Breaking Biology Technology:Shimadzu Nexera UC Recognized at Pittcon 2015 with Editors’ Gold Award 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4
... Guidance of $350 million to $360 million, WARSAW, ... ), an independent provider of products to the global ... quarter 2007 revenue of $79.1 million. The Company stated ... time., As previously announced on October 4, 2007, ...
... Sanofi-aventis announced,today that the Chicago Athenaeum Museum of ... Award for the new SoloSTAR(R) disposable,insulin injection pen ... diabetes., "LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the ... been designed in dialogue with,patients, nurses and doctors ...
... researchers at the Georgia Institute of Technology are developing ... motion and converts it into electricity for powering small ... and other users. , The research, funded by ... Feb. 14 issue of Nature, details how pairs of ...
Cached Biology Technology:Symmetry Medical Reports Preliminary Fourth Quarter Revenue 2Symmetry Medical Reports Preliminary Fourth Quarter Revenue 3Symmetry Medical Reports Preliminary Fourth Quarter Revenue 4Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 2Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 3Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 4Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 5Remarkable new clothing may someday power your iPod 2
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
(Date:3/23/2015)... OXFORD, Conn. , Mar. 23, 2015 NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, announces ... a new advertising campaign on CNBC television starting March 30 ... ads will commence airing in New York ... Executive Officer said: "We are excited about our new ad ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... a genetic cause of a mysterious neurological disease in ... illness, Primary Progressive Aphasia, differs from Alzheimer's Disease in ... a little known form of dementia, people lose the ... , "This discovery, for the first time, provides a ...
... often cause dramatic symptoms such as the formation of ... fungi can even make infected plants smell like rotting ... farmers who are counting on their crops, such as ... , Natural Sciences and Engineering Research Council (NSERC) ...
... Natural Sciences and Engineering Research Council grantee Robert Reisz discovering ... that stands on two legs. , Now, he is ... by joining the ranks of the American Association for the ... a fellow during its annual conference, being held from Feb. ...
Cached Biology News:Researchers discover genetic cause for word-finding disease 2Stopping plants from getting sick 2Old dinosaur research leads to new honor 2